Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors

Palmarisa Franchetti, Loredana Cappellacci, Michela Pasqualini, Riccardo Petrelli, Vetrichelvan Jayaprakasan, Hiremagalur N. Jayaram, Donald B. Boyd, Manojkumar D. Jain, Mario Grifantini

Research output: Contribution to journalArticle

23 Citations (Scopus)

Abstract

Thiazole-4-carboxamide adenine dinucleotide (TAD) analogues T-2′-MeAD (1) and T-3′-MeAD (2) containing, respectively, a methyl group at the ribose 2′-C-, and 3′-C-position of the adenosine moiety, were prepared as potential selective human inosine monophosphate dehydrogenase (IMPDH) type II inhibitors. The synthesis of heterodinucleotides was carried out by CDI-catalyzed coupling reaction of unprotected 2′-C-methyl- or 3′-C-methyl-adenosine 5′-monophosphate with 2′,3′-O- isopropylidene-tiazofurin 5′-monophosphate, and then deisopropylidenation. Biological evaluation of dinucleotides 1 and 2 as inhibitors of recombinant human IMPDH type I and type II resulted in a good activity. Inhibition of both isoenzymes by T-2′-MeAD and T-3′-MeAD was noncompetitive with respect to NAD substrate. Binding of T-3′-MeAD was comparable to that of parent compound TAD, while T-2′-MeAD proved to be a weaker inhibitor. However, no significant difference was found in inhibition of the IMPDH isoenzymes. T-2′-MeAD and T-3′-MeAD were found to inhibit the growth of K562 cells (IC50 30.7 and 65.0 μM, respectively).

Original languageEnglish
Pages (from-to)2045-2053
Number of pages9
JournalBioorganic and Medicinal Chemistry
Volume13
Issue number6
DOIs
StatePublished - Mar 15 2005

Fingerprint

IMP Dehydrogenase
Inosine Monophosphate
Bioactivity
tiazofurin
Adenosine
Isoenzymes
Oxidoreductases
Ribose
K562 Cells
Adenosine Monophosphate
NAD
Inhibitory Concentration 50
Substrates
Growth
thiazole-4-carboxamide adenine dinucleotide
human IMPDH2 protein

Keywords

  • Cytotoxicity
  • IMPDH inhibitors
  • TAD analogues

ASJC Scopus subject areas

  • Biochemistry
  • Molecular Biology
  • Organic Chemistry
  • Drug Discovery
  • Pharmaceutical Science

Cite this

Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors. / Franchetti, Palmarisa; Cappellacci, Loredana; Pasqualini, Michela; Petrelli, Riccardo; Jayaprakasan, Vetrichelvan; Jayaram, Hiremagalur N.; Boyd, Donald B.; Jain, Manojkumar D.; Grifantini, Mario.

In: Bioorganic and Medicinal Chemistry, Vol. 13, No. 6, 15.03.2005, p. 2045-2053.

Research output: Contribution to journalArticle

Franchetti, P, Cappellacci, L, Pasqualini, M, Petrelli, R, Jayaprakasan, V, Jayaram, HN, Boyd, DB, Jain, MD & Grifantini, M 2005, 'Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors', Bioorganic and Medicinal Chemistry, vol. 13, no. 6, pp. 2045-2053. https://doi.org/10.1016/j.bmc.2005.01.007
Franchetti, Palmarisa ; Cappellacci, Loredana ; Pasqualini, Michela ; Petrelli, Riccardo ; Jayaprakasan, Vetrichelvan ; Jayaram, Hiremagalur N. ; Boyd, Donald B. ; Jain, Manojkumar D. ; Grifantini, Mario. / Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors. In: Bioorganic and Medicinal Chemistry. 2005 ; Vol. 13, No. 6. pp. 2045-2053.
@article{fb1dca78f30a4403a81d5be21a04ff41,
title = "Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors",
abstract = "Thiazole-4-carboxamide adenine dinucleotide (TAD) analogues T-2′-MeAD (1) and T-3′-MeAD (2) containing, respectively, a methyl group at the ribose 2′-C-, and 3′-C-position of the adenosine moiety, were prepared as potential selective human inosine monophosphate dehydrogenase (IMPDH) type II inhibitors. The synthesis of heterodinucleotides was carried out by CDI-catalyzed coupling reaction of unprotected 2′-C-methyl- or 3′-C-methyl-adenosine 5′-monophosphate with 2′,3′-O- isopropylidene-tiazofurin 5′-monophosphate, and then deisopropylidenation. Biological evaluation of dinucleotides 1 and 2 as inhibitors of recombinant human IMPDH type I and type II resulted in a good activity. Inhibition of both isoenzymes by T-2′-MeAD and T-3′-MeAD was noncompetitive with respect to NAD substrate. Binding of T-3′-MeAD was comparable to that of parent compound TAD, while T-2′-MeAD proved to be a weaker inhibitor. However, no significant difference was found in inhibition of the IMPDH isoenzymes. T-2′-MeAD and T-3′-MeAD were found to inhibit the growth of K562 cells (IC50 30.7 and 65.0 μM, respectively).",
keywords = "Cytotoxicity, IMPDH inhibitors, TAD analogues",
author = "Palmarisa Franchetti and Loredana Cappellacci and Michela Pasqualini and Riccardo Petrelli and Vetrichelvan Jayaprakasan and Jayaram, {Hiremagalur N.} and Boyd, {Donald B.} and Jain, {Manojkumar D.} and Mario Grifantini",
year = "2005",
month = "3",
day = "15",
doi = "10.1016/j.bmc.2005.01.007",
language = "English",
volume = "13",
pages = "2045--2053",
journal = "Bioorganic and Medicinal Chemistry",
issn = "0968-0896",
publisher = "Elsevier Limited",
number = "6",

}

TY - JOUR

T1 - Synthesis, conformational analysis, and biological activity of new analogues of thiazole-4-carboxamide adenine dinucleotide (TAD) as IMP dehydrogenase inhibitors

AU - Franchetti, Palmarisa

AU - Cappellacci, Loredana

AU - Pasqualini, Michela

AU - Petrelli, Riccardo

AU - Jayaprakasan, Vetrichelvan

AU - Jayaram, Hiremagalur N.

AU - Boyd, Donald B.

AU - Jain, Manojkumar D.

AU - Grifantini, Mario

PY - 2005/3/15

Y1 - 2005/3/15

N2 - Thiazole-4-carboxamide adenine dinucleotide (TAD) analogues T-2′-MeAD (1) and T-3′-MeAD (2) containing, respectively, a methyl group at the ribose 2′-C-, and 3′-C-position of the adenosine moiety, were prepared as potential selective human inosine monophosphate dehydrogenase (IMPDH) type II inhibitors. The synthesis of heterodinucleotides was carried out by CDI-catalyzed coupling reaction of unprotected 2′-C-methyl- or 3′-C-methyl-adenosine 5′-monophosphate with 2′,3′-O- isopropylidene-tiazofurin 5′-monophosphate, and then deisopropylidenation. Biological evaluation of dinucleotides 1 and 2 as inhibitors of recombinant human IMPDH type I and type II resulted in a good activity. Inhibition of both isoenzymes by T-2′-MeAD and T-3′-MeAD was noncompetitive with respect to NAD substrate. Binding of T-3′-MeAD was comparable to that of parent compound TAD, while T-2′-MeAD proved to be a weaker inhibitor. However, no significant difference was found in inhibition of the IMPDH isoenzymes. T-2′-MeAD and T-3′-MeAD were found to inhibit the growth of K562 cells (IC50 30.7 and 65.0 μM, respectively).

AB - Thiazole-4-carboxamide adenine dinucleotide (TAD) analogues T-2′-MeAD (1) and T-3′-MeAD (2) containing, respectively, a methyl group at the ribose 2′-C-, and 3′-C-position of the adenosine moiety, were prepared as potential selective human inosine monophosphate dehydrogenase (IMPDH) type II inhibitors. The synthesis of heterodinucleotides was carried out by CDI-catalyzed coupling reaction of unprotected 2′-C-methyl- or 3′-C-methyl-adenosine 5′-monophosphate with 2′,3′-O- isopropylidene-tiazofurin 5′-monophosphate, and then deisopropylidenation. Biological evaluation of dinucleotides 1 and 2 as inhibitors of recombinant human IMPDH type I and type II resulted in a good activity. Inhibition of both isoenzymes by T-2′-MeAD and T-3′-MeAD was noncompetitive with respect to NAD substrate. Binding of T-3′-MeAD was comparable to that of parent compound TAD, while T-2′-MeAD proved to be a weaker inhibitor. However, no significant difference was found in inhibition of the IMPDH isoenzymes. T-2′-MeAD and T-3′-MeAD were found to inhibit the growth of K562 cells (IC50 30.7 and 65.0 μM, respectively).

KW - Cytotoxicity

KW - IMPDH inhibitors

KW - TAD analogues

UR - http://www.scopus.com/inward/record.url?scp=13844311803&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=13844311803&partnerID=8YFLogxK

U2 - 10.1016/j.bmc.2005.01.007

DO - 10.1016/j.bmc.2005.01.007

M3 - Article

VL - 13

SP - 2045

EP - 2053

JO - Bioorganic and Medicinal Chemistry

JF - Bioorganic and Medicinal Chemistry

SN - 0968-0896

IS - 6

ER -